IMAGE: Lung squamous cell carcinoma

Breaking News

Key: Meeting M      Journal J      Funder F

Showing releases 926-950 out of 1422.

<< < 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 > >>

Public Release: 1-Apr-2016
Cancer Epidemiology, Biomarkers & Prevention
New study links coffee consumption to decreased risk of colorectal cancer
Researchers at the University of Southern California (USC) Norris Comprehensive Cancer Center of Keck Medicine of USC have found that coffee consumption, including decaf, instant and espresso, decreases the risk of colorectal cancer. Moreover, these benefits increase the more coffee you drink.

Contact: Mary Dacuma
University of Southern California - Health Sciences

Public Release: 31-Mar-2016
'Cancer gene' twice as likely to be defective in children with autism
A large study by researchers with the UC Davis MIND Institute has found that a gene whose role is to suppress cellular damage from environmental stressors is nearly twice as likely to be defective in children with autism spectrum disorder, and that the deficit is also present in their fathers.
Simons Foundation Autism Research Initiative, NIH/National Institute of Environmental Health Sciences

Contact: Phyllis Brown
University of California - Davis Health System

Public Release: 31-Mar-2016
Aplidin shows positive results in pivotal Phase 3 clinical trial for multiple myeloma
Aplidin® has shown a statistically significant 35 percent reduction in the risk of progression or death over the comparator (p=0.0054). The study has met its primary endpoint.

Contact: Paula Fernández

Public Release: 31-Mar-2016
Cell Chemical Biology
Living off the fat of the land
For more than 80 years scientists have thought that cancer cells fuel their explosive growth by soaking up glucose from the blood, using its energy and atoms to crank out duplicate sets of cellular components. But is this really true? Work in a metabolomics laboratory at Washington University in St. Louis suggests not.

Contact: Diana Lutz
Washington University in St. Louis

Public Release: 31-Mar-2016
MicroRNA controls growth in highly aggressive B-cell lymphomas
A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine showed that a microRNA called miR-181a dampens signals from the cancer-driving NFκB protein pathway in the most aggressive large B-cell lymphomas.
Lymphoma Research Foundation

Contact: Patrick Bartosch
University of Miami Miller School of Medicine

Public Release: 31-Mar-2016
JAMA Oncology
Short overnight fasting linked to increased risk of breast cancer recurrence
In patients with breast cancer, a short overnight fast of less than 13 hours was associated with a statistically significant, 36 percent higher risk of breast cancer recurrence and a non-significant, 21 percent higher probability of death from the disease compared to patients who fasted 13 or more hours per night, report University of California, San Diego School of Medicine researchers.
NIH/National Cancer Institute

Contact: Yadira Galindo
University of California - San Diego

Public Release: 31-Mar-2016
JAMA Oncology
Prolonged nightly fasting may reduce risk of breast cancer recurrence
Fasting less than 13 hours per night was associated with an increased risk for breast cancer recurrence in women with early-stage breast cancer, according to an article published online by JAMA Oncology.

Contact: Yadira Galindo
The JAMA Network Journals

Public Release: 31-Mar-2016
JAMA Oncology
Urine test improves prediction of high-grade prostate cancer
A study published online in JAMA Oncology showed that an experimental urine test that detects genetic changes associated with prostate cancer identified 92 percent of men with elevated PSA levels who had more aggressive disease.

Contact: Karin Eskenazi
Columbia University Medical Center

Public Release: 31-Mar-2016
Journal of Adolescent and Young Adult Oncology
Helping young adult cancer survivors adopt a healthy lifestyle
A healthy lifestyle is especially important for young adult and teenage survivors of cancer, and how health behavior messages related to diet, exercise, smoking, and alcohol consumption are developed and presented may impact their effectiveness in this population, according to an article in Journal of Adolescent and Young Adult Oncology (JAYAO).

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 31-Mar-2016
Plastic and Reconstructive Surgery
Ibuprofen doesn't increase bleeding risk after plastic surgery
Patients are often instructed not to take ibuprofen and other nonsteroidal anti-inflammatory drugs before or after surgery because of increased bleeding risk. But available evidence suggests that ibuprofen does not increase the risk of bleeding after plastic surgery procedures, according to a research review in the April issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons.

Contact: Connie Hughes
Wolters Kluwer Health

Public Release: 31-Mar-2016
TGen and Mayo Clinic scientists issue report in Cell on advances in basal cell carcinoma
An article in the journal Cell by top scientists from the Translational Genomics Research Institute (TGen) and Mayo Clinic in Arizona details how two relatively new drugs are helping patients with basal cell carcinoma. Basal cell carcinoma is the most common type of skin cancer, producing nearly 2.8 million new cases annually in the US, and sunny Arizona has one of the world's highest incidences of skin cancer.

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Public Release: 31-Mar-2016
Clinical Cancer Research
Histone deacetylase inhibitors enhance immunotherapy in lung cancer models, say Moffitt researchers
Several new immunotherapeutic antibodies that inhibit checkpoint receptors on T cells to restimulate the immune system to target tumors have been approved to treat advanced stage lung cancer and melanoma; however, only 20 percent of lung cancer patients show a response to these agents. Moffitt Cancer Center researchers have identified a class of drugs that improve the activity of immunotherapeutic antibodies by stimulating the movement of T cells into a tumor and enhancing their activity.
National Institutes of Health

Contact: Lisa Chillura
H. Lee Moffitt Cancer Center & Research Institute

Public Release: 31-Mar-2016
Research Ideas & Outcomes
Better cancer care for Indigenous Canadians with arts and dialogue in a new proposal
While the number of Indigenous Canadians diagnosed with cancer is growing, little is done to study and address their unique needs in a timely manner. Dr. Chad Hammond suggests an innovative research design, based on arts-based, participatory dialogue with stakeholders involved in cancer care for First Nation, Inuit, and Métis peoples. His grant proposal, submitted to the Canadian Institutes of Health Research postdoctoral fellowship competition, is published in the open-access journal Research Ideas and Outcomes.

Contact: Chad Hammond
Pensoft Publishers

Public Release: 31-Mar-2016
New study implicates unusual class of circular RNAs in cancer
Cancer cells are notorious for their genomes gone haywire, often yielding fusion proteins -- mash-ups of two disparate genes that, once united, assume new and harmful capabilities. Exactly how such genome scrambling impacts RNA, particularly the vast and mysterious world of non-coding RNA, has been largely unexplored.
National Institutes of Health

Contact: Jennifer Kritz
Beth Israel Deaconess Medical Center

Public Release: 31-Mar-2016
Clinical Cancer Research
Brain cancer: Two essential amino acids might hold key to better outcomes
A new study suggests that the altered metabolism of two essential amino acids helps drive the development of the most common and lethal form of brain cancer. The findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely. The study shows that in glioblastoma, the essential amino acids methionine and tryptophan are abnormally metabolized due to the loss of key enzymes in GBM cells.
NIH/National Cancer Institute

Contact: Darrell E. Ward
Ohio State University Wexner Medical Center

Public Release: 30-Mar-2016
Study confirms link between diabetes drug and increased risk of bladder cancer
The diabetes drug pioglitazone is associated with an increased risk of bladder cancer, finds a study published by The BMJ today. The findings suggest that the risk increases with increasing duration of use and dose.

Contact: Emma Dickinson

Public Release: 30-Mar-2016
American Journal of Clinical Nutrition
Eating beans, peas, chickpeas or lentils may help lose weight and keep it off
Eating one serving a day of beans, peas, chickpeas or lentils could contribute to modest weight loss, a new study suggests.
Canadian Institutes of Health Research

Contact: Leslie Shepherd
St. Michael's Hospital

Public Release: 30-Mar-2016
Science Translational Medicine
Cancer drug could treat blood vessel deformities
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin, finds new research in mice led by UCL, Memorial Sloan Kettering Cancer Center in New York and the Bellvitge Biomedical Research Institute in Barcelona. The findings are published in two independent but complementary papers in Science Translational Medicine, led by UCL and MSK respectively.

Contact: Harry Dayantis
University College London

Public Release: 30-Mar-2016
UT Southwestern scientists identify structure of crucial enzyme in cell division
UT Southwestern Medical Center researchers have determined the atomic structure of an enzyme that plays an essential role in cell division, the fundamental process that occurs countless times daily in many life forms on Earth.
Cancer Prevention and Research Institute of Texas, National Institutes of Health, and Welch Foundation

Contact: Deborah Wormser
UT Southwestern Medical Center

Public Release: 30-Mar-2016
Science Translational Medicine
Cancer gene drives vascular disorder
Two research teams have uncovered mutations in a well-known cancer gene that may drive the most common form of blood vessel abnormality, venous malformations, in some patients.

Contact: Science Press Package
American Association for the Advancement of Science

Public Release: 30-Mar-2016
Cancer Discovery
New mouse model for acute myeloid leukemia opens door to research, possible treatments
A novel mouse model of a highly lethal form of acute myeloid leukemia (AML) offers a new tool for scientists working to better understand this disease and research new therapeutic targets.
Ladies Auxiliary to the Veterans of Foreign Wars Postdoctoral Fellowship, CancerFree KIDS, University of Cincinnati, Cincinnati Children's, Leukemia and Lymphoma Society, NHLBI Progenitor Cell Biology Consortium, National Institutes of Health

Contact: Jim Feuer
Cincinnati Children's Hospital Medical Center

Public Release: 30-Mar-2016
Clinical Cancer Research
New compounds may aid in development of targeted therapies for a rare pediatric cancer
Two recently discovered compounds have shown promise in preclinical studies for treating Ewing sarcoma, a rare cancer that predominantly affects children and adolescents.

Contact: Beth Hinshaw Hall
Van Andel Research Institute

Public Release: 30-Mar-2016
42nd Annual Meeting of the European Society for Blood and Marrow Transplantation
Cyclophosphamide, old dogs with new tricks?
During the EBMT Annual Meeting, many sessions and international speakers will discuss in depth the rejuvenated role of cyclophosphamide in stem cell transplantation.

Contact: Mélanie Chaboissier
European Society for Blood and Marrow Transplantation

Public Release: 30-Mar-2016
European Respiratory Journal
High numbers of patients in poorer countries are missing lung cancer tests and treatment
Severe inequalities exist between countries regarding the availability of an essential lung cancer test and a drug which together can improve outcomes for patients through a personalised approach to treatment.

Contact: Lauren Anderson
European Lung Foundation

Public Release: 30-Mar-2016
Genes and Development
Gene variant may contribute to increased cancer risk in African-Americans
New research from The Wistar Institute has pinpointed a single variant in a gene that is only found in Africans and African-Americans, which makes cancer resistant to cell death and may contribute to increased cancer risk.
National Institutes of Health, NIH/National Institute of Environmental Health Sciences

Contact: Ben Leach
The Wistar Institute

Showing releases 926-950 out of 1422.

<< < 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 > >>

  Search News Releases